What we found on the web about Efalizumab
Efalizumab (trade name Raptiva, Genentech, Merck Serono) is a medication designed to treat psoriasis. As its name implies, it is a recombinant humanized monoclonal antibody that ...
These include efalizumab, rituximab, [4] infliximab, [5] natalizumab, [6] chemotherapy, [7] corticosteroids, [8] and various transplant drugs such as tacrolimus.
Research Raptiva Efalizumab information, news and resources on drug recalls such as Raptiva. If you've experienced health complications while using the Raptiva drug, you may have ...
Treatment with an immunosuppressant such as efalizumab may increase the risk of developing certain types of cancer (e.g., lymphoma). Talk to your doctor about the ...
efalizumab glossary includes a list of efalizumab related medical definitions and related links on MedicineNet.com ... efalizumab Index. efalizumab, Raptiva ...
Efalizumab is a prescription drug used for the treatment of adults with chronic plaque psoriasis. Chronic plaque psoriasis is an auto-inflammatory condition in which cells collect ...
Efalizumab is used to treat chronic long-lasting plaque psoriasis a skin disease ... Never mix efalizumab powder with any liquid other than the sterile water provided. ...
Archives of Dermatology is a monthly professional medical journal published by the American Medical Association. Archives of Dermatology publishes original, peer-reviewed reports ...
This information has been developed and provided by an independent third-party source. Merck & Co., Inc. does not endorse and is not responsible for the accuracy of the content, or ...
Efalizumab Generic Name . Efalizumab. Brand Names . Raptiva. General Information . Efalizumab is a synthetic antibody that is used for the treatment of psoriasis.
Here is what users have to say about Efalizumab

Efalizumab (trade name Raptiva, Genentech, Merck Serono) is a medication designed to treat psoriasis. As its name implies, it is a recombinant humanized monoclonal antibody that binds to CD11a and acts as an immunosuppressant. It is administered once weekly by subcutaneous injection. It acts to inhibit white blood cell migration out of blood vessels into tissues. Because it suppresses the immune system, it has been associated with fatal brain infections, and has been withdrawn from the market.

Welcome to CWAnswers

CWAnswers is your guide to the sprawling world wide web. The directory aims to provide a useful guide made by users. You can share your knowledge as well - simply register and edit your first entry. For questions just contact the team at support - at - cwanswers.com.

Weblinks

Top 10

Things you find nowhere else.

Comments

You must be logged in to post a comment.

No comments yet on this topic. Be the first one!